RECURRENCE
Clinical trials for RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RECURRENCE trials appear
Sign up with your email to follow new studies for RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI picks who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study tests whether a computer model can help decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from coming back. About 300 adults who had their liver cancer completely removed will be enrolled. The goal is …
Matched conditions: RECURRENCE
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 07:01 UTC
-
Poop pills could stop deadly bile duct infections from coming back
Disease control Not yet recruitingThis study tests whether transplanting gut bacteria from healthy donors (via capsules) can prevent repeat episodes of acute cholangitis, a serious bile duct infection. About 44 adults who have had at least two infections in the past year will receive either fecal transplants or s…
Matched conditions: RECURRENCE
Phase: PHASE2 • Sponsor: Puerta de Hierro University Hospital • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Cheap drug may slash lung cancer return after surgery
Disease control Not yet recruitingThis study tests whether giving the numbing drug lidocaine during lung cancer surgery can lower the chance of the cancer returning or spreading. About 1,400 adults having minimally invasive lung cancer surgery will be randomly assigned to receive lidocaine or a placebo. Researche…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Virus injected into brain tumors shows promise for kids with no other options
Disease control Not yet recruitingThis study tests a treatment called DNX-2401, a virus that is injected directly into brain tumors to kill cancer cells. It is for children and young adults (up to age 39) whose high-grade brain tumors have come back or not responded to standard treatments. The goal is to see if t…
Matched conditions: RECURRENCE
Phase: PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Blood test may predict liver cancer return and guide treatment
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tiny bits of tumor DNA can predict if liver cancer will come back after surgery. It will involve 276 people who had their liver cancer removed. The goal is to see if this test can also help decide who might benefit from additi…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:52 UTC
-
Blood test may spot hidden cancer return months before scans
Knowledge-focused Not yet recruitingThis study tests whether regular blood tests (ctDNA) can detect the return of triple-negative breast cancer earlier than standard follow-up. Thirty participants who finished treatment will be randomly assigned to usual care or usual care plus blood tests. The goal is to see if th…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC